Tag Archives: Jay Bradner M.D.

Novartis, Pear Therapeutics to work together towards developing new treatments for patients with schizophrenia and multiple sclerosis

Posted on 6, March 2018 by

Novartis and Pear Therapeutics to collaborate on prescription software applications aimed to treat patients with schizophrenia and multiple sclerosis Collaboration combines Novartis’ leadership in biomedical research and clinical development with Pear’s expertise in digital therapeutics  Novartis continues to embrace emerging … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Switzerland

Tagged , , , , , , , ,